SNCA and Parkinson disease: In conclusion, our study suggests that non-invasive determination of α-synuclein-positive EVs, with or without PARP activity, offers a non-invasive marker of disease progression in PD and may also identify a subtype of PD with unique biological and biochemical characteristics.